Get the Stockscreener App
11.36
2.66%
-0.31
Pre-market:
11.36
Transcode Therapeutics Inc stock is traded at $11.36, with a volume of 8,056.
It is down -2.66% in the last 24 hours and up +5.28% over the past month.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.
See More
Previous Close:
$11.67
Open:
$11.3956
24h Volume:
8,056
Relative Volume:
0.26
Market Cap:
$9.47M
Revenue:
-
Net Income/Loss:
$-14.93M
P/E Ratio:
-0.0427
EPS:
-266.137
Net Cash Flow:
$-15.87M
1W Performance:
+6.17%
1M Performance:
+5.28%
6M Performance:
-47.99%
1Y Performance:
-95.76%
1-Day Range:
$11.15
$11.76
1-Week Range:
$10.66
$11.76
52-Week Range:
$6.1478
$739.20
Transcode Therapeutics Inc Stock (RNAZ) Company Profile
Name
Transcode Therapeutics Inc
Sector
Industry
Phone
857-301-6857
Address
6 LIBERTY SQUARE, BOSTON
Compare RNAZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RNAZ
Transcode Therapeutics Inc
|
11.36 | 9.73M | 0 | -14.93M | -15.87M | -266.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.15 | 100.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.50 | 60.95B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.73 | 60.46B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
734.35 | 46.04B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.20 | 36.02B | 3.81B | -644.79M | -669.77M | -6.24 |
Transcode Therapeutics Inc Stock (RNAZ) Latest News
How to monitor TransCode Therapeutics Inc. with trend dashboardsRecession Risk & Safe Capital Investment Plans - newser.com
Smart tools for monitoring TransCode Therapeutics Inc.’s price action2025 Technical Overview & Reliable Volume Spike Alerts - newser.com
How to track smart money flows in TransCode Therapeutics Inc.Weekly Trade Report & Free Safe Capital Growth Stock Tips - newser.com
Is TransCode Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Macro Moves & AI Enhanced Trading Signals - newser.com
What high frequency data says about TransCode Therapeutics Inc.2025 Analyst Calls & AI Driven Price Predictions - newser.com
How high can TransCode Therapeutics Inc. stock go2025 Buyback Activity & Consistent Profit Focused Trading Strategies - newser.com
Chart based exit strategy for TransCode Therapeutics Inc.Weekly Market Report & Safe Entry Trade Signal Reports - newser.com
Investment Review: Is TransCode Therapeutics Inc undervalued by DCF analysisAnalyst Upgrade & Verified Chart Pattern Signals - خودرو بانک
Big Picture: Is RILYP exposed to currency risksDip Buying & Safe Entry Point Identification - خودرو بانک
Is TransCode Therapeutics Inc. stock bottoming outMarket Trend Summary & Risk Managed Trade Strategies - newser.com
Volatility clustering patterns for TransCode Therapeutics Inc.2025 Market Outlook & Long Hold Capital Preservation Tips - newser.com
Update Recap: Can TransCode Therapeutics Inc sustain its profitability2025 Geopolitical Influence & Technical Pattern Recognition Alerts - خودرو بانک
RSI Check: Why is TransCode Therapeutics Inc stock going downQuarterly Trade Review & Free Real-Time Market Sentiment Alerts - خودرو بانک
Developing predictive dashboards with TransCode Therapeutics Inc. dataJuly 2025 Action & Risk Managed Trade Strategies - newser.com
Applying Wyckoff theory to TransCode Therapeutics Inc. stockDay Trade & Technical Pattern Based Signals - newser.com
Market Pulse: Is TransCode Therapeutics Inc.’s ROE strong enough2025 Historical Comparison & AI Forecast Swing Trade Picks - خودرو بانک
Institution Moves: Can Plus Therapeutics Inc stock double in the next year2025 Major Catalysts & Low Risk High Win Rate Stock Picks - خودرو بانک
TransCode Therapeutics Inc. stock volume spike explainedEarnings Recap Summary & Reliable Price Action Trade Plans - newser.com
Merger Talk: Is TransCode Therapeutics Inc.’s ROE strong enoughJuly 2025 Final Week & AI Enhanced Trading Signals - خودرو بانک
Aug Wrap: Why is TransCode Therapeutics Inc stock going down2025 Fundamental Recap & Community Verified Trade Alerts - خودرو بانک
Should I add TransCode Therapeutics Inc. stock to my portfolioJuly 2025 Levels & Real-Time Price Movement Reports - خودرو بانک
Insider Sell: Is Ernexa Therapeutics Inc. a speculative investment2025 Market Overview & Risk Controlled Swing Alerts - خودرو بانک
Gainers Report: Does TransCode Therapeutics Inc have pricing powerIPO Watch & Capital Efficiency Focused Strategies - خودرو بانک
Options Flow: What are analysts price targets for TransCode Therapeutics IncWall Street Watch & Comprehensive Market Scan Reports - خودرو بانک
Risk Off: What is INLIF Limited s revenue forecastTrade Volume Report & Precise Swing Trade Alerts - خودرو بانک
Is TransCode Therapeutics Inc. still worth holding after the dipEarnings Trend Report & Weekly Return Optimization Alerts - Newser
Can TransCode Therapeutics Inc. recover in the next quarterPortfolio Performance Report & Daily Volume Surge Trade Alerts - Newser
Visual analytics tools that track TransCode Therapeutics Inc. performanceWeekly Stock Report & Short-Term High Return Ideas - Newser
What institutional flow reveals about TransCode Therapeutics Inc.July 2025 Breakouts & AI Driven Stock Price Forecasts - Newser
TransCode Therapeutics Inc. stock trendline breakdown2025 Buyback Activity & Daily Profit Focused Screening - Newser
Is TransCode Therapeutics Inc. stock entering bullish territoryRisk Management & Consistent Profit Alerts - Newser
Using AI based signals to follow TransCode Therapeutics Inc.Portfolio Value Report & Consistent Income Trade Recommendations - Newser
Technical analysis overview for TransCode Therapeutics Inc. stockMarket Movement Recap & Expert Approved Momentum Ideas - Newser
will transcode therapeutics inc. continue its uptrendJuly 2025 Momentum & Stepwise Entry/Exit Trade Alerts - Newser
Can volume confirm reversal in TransCode Therapeutics Inc.2025 Stock Rankings & Weekly Breakout Stock Alerts - Newser
Will TransCode Therapeutics Inc. continue its uptrend2025 Investor Takeaways & AI Powered Market Entry Ideas - Newser
TransCode Therapeutics Inc. stock outlook for YEARJuly 2025 Closing Moves & Free Low Drawdown Momentum Trade Ideas - Newser
Transcode Therapeutics Inc Stock (RNAZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):